Andreas Lind
Position: Research scientist, MD, PhD
Phone: +47 221 18851
Email:
 

Author network for Andreas Lind by COREMINE medical


Publications 2017

Rachman L, Liuni M, Arias P, Lind A, Johansson P, Hall L, Richardson D, Watanabe K, Dubal S, Aucouturier JJ (2017)
DAVID: An open-source platform for real-time transformation of infra-segmental emotional cues in running speech
Behav Res Methods (in press)
PubMed 28374144

Publications 2016

Lind A, Wängberg B, Ellegård L (2016)
Vitamin D and vitamin B12 deficiencies are common in patients with midgut carcinoid (SI-NET)
Eur J Clin Nutr, 70 (9), 990-4
PubMed 27026421

Plicht B, Lind A, Erbel R (2016)
[Infective endocarditis : New ESC guidelines 2015]
Internist (Berl), 57 (7), 675-90
PubMed 27307162

Prebensen C, Lind A, Dyrhol-Riise AM, Kvale D (2016)
Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
PLoS One, 11 (4), e0153849
PubMed 27128502

Publications 2015

Prebensen C, Ueland T, Michelsen AE, Lind A, Pettersen FO, Mollnes TE, Aukrust P, Dyrhol-Riise AM, Kvale D (2015)
High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
J Acquir Immune Defic Syndr, 69 (4), 395-402
PubMed 26115437

Publications 2014

Brekke K, Lind A, Holm-Hansen C, Haugen IL, Sørensen B, Sommerfelt M, Kvale D (2014)
Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial
PLoS One, 9 (11), e112556
PubMed 25398137

Kran AMB, Lind A, Sommerfelt MM, Baksaas I, Sørensen B, Kvale D (2014)
Comparable Cellular Immune Responses in Patients with and without Antiretroviral Treatment after Immunization with HIV-1 P24, P17 and Tat Consensus Peptides (Vacc-5q)
J AIDS Clin Res, 5 (4), 1000294
PublikaID 217

Lind A, Brekke K, Pettersen FO, Mollnes TE, Trøseid M, Kvale D (2014)
A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
PLoS One, 9 (1), e85604
PubMed 24416431

Publications 2013

Lind A, Brekke K, Sommerfelt M, Holmberg JO, Aass HC, Baksaas I, Sørensen B, Dyrhol-Riise AM, Kvale D (2013)
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
Vaccine, 31 (41), 4611-8
PubMed 23906886

Publications 2012

Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D (2012)
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
Scand J Infect Dis, 44 (8), 566-72
PubMed 22339485

Trøseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen KK, Kanda T, Funaoka H, Damås JK, Kvale D (2012)
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
Innate Immun, 19 (3), 290-7
PubMed 23070967

Publications 2011

Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
PubMed 21490090

Publications 2009

Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
J Clin Microbiol, 47 (7), 2170-4
PubMed 19420166